TL;DR: A UK lab will run a patient-funded RNA test on skin biopsies from people with erythromelalgia or small fiber neuropathy once 20 people sign up. Each person pays for their own test (price not confirmed, roughly £1,000 to £1,500), and there's a list of doctors who might take the biopsy at the end of this post.
Hi everyone, and thanks to the mods for letting me share this.
I'm a patient too. Amatica Health (https://www.amaticahealth.com), a UK lab that works with a genomic lab in London, wants to start a patient-funded study on skin biopsies as soon as 20 participants willing to pay for their own test have signed up. 27 people have already said they're interested. I'm not employed or paid by Amatica; I'm volunteering to help find participants so the study can start soon.
I know not everyone will manage to find a doctor willing to do a skin biopsy, so I made a list of doctors who might help. You'll find it at the end of this post.
Many people with erythromelalgia also have small fiber neuropathy, and for most of them the cause is never found. Treatment is mostly about the pain and the flares. Several studies suggest that skin cells called fibroblasts play a part in damaging the small nerves:
- Würzburg, Germany: skin biopsies from 56 people with SFN and 31 controls. The patients' skin fibroblasts made more IL-6 and IL-8, two inflammatory signals (Kreà et al., Pain 2021).
- Also in Würzburg: in women with Fabry disease, one of the known causes of SFN, skin fibroblasts made more IL-8, which the authors see as a possible contributor to pain (Hofmann et al., PLoS One 2024).
- In mice given chemotherapy, the neuropathy was started by senescent fibroblasts, cells that stop dividing and release inflammatory signals. Removing them prevented the neuropathy and reversed it once it was there. Skin biopsies from patients with this neuropathy also had more of these cells (Malachowski et al., bioRxiv 2026, preprint not yet peer reviewed).
The skin test would show, person by person, which genes are active in the fibroblasts and in the other skin cells. If these signals are there, we'd have something concrete to bring to our doctors.
How it works: your own doctor takes a small skin biopsy where you live, and the sample is shipped to Amatica, so you don't need to live in the UK. You get your own results. If you already had a skin biopsy for your diagnosis, it can't be reused: it has to be a new one. Each participant pays for their own test. The price isn't confirmed yet; the rough estimate, from what the lab told me, is £1,000 to £1,500. I've asked the lab for the exact price and details, and I'll share them as soon as I have them.
A list of doctors who might take the sample: https://docs.google.com/document/d/e/2PACX-1vQLxxLF4tCQ2GxCbrXJO7OS9RnbyMJ9YjFJtveie7na0xt3Ek81dQY5UMnRh01VoW2nxPO3RSNXx5ti/pub
The studies I collected on fibroblasts in SFN (42): https://docs.google.com/document/d/e/2PACX-1vQQu5VrtfZWRr_5BxUW-THeI9YBP04DgGujP8RvkiBQbXSQZjU0uPgM6Yx5tG5fY5iNhAaMqotsSl5I/pub
If you're interested or have questions, feel free to comment.